Gou, H., Zheng, L., Xiao, X., Wang, L., Li, H., Ying, J., Pan, Y., Ni, S., Niu, Z., Zhang, J., Lu, L., Lin, X., He, W., Zhai, W., Yang, W., Bai, B., Yao, P., Cui, H., Hu, J. (2026). A phase 1 study of SHR-3821, an ADCC-enhanced CLDN18.2/4-1BB bispecific antibody, in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4037